| - IKF/AIO-QUINTIS - Evaluating Fruquintinib in Combination With Tislelizumab in Microsatellite S | Phase II | rekrutiert |
| A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed Wit | Phase III | rekrutiert |
| A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Trea | Phase I / Phase II | rekrutiert |
| A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Co | Phase II / Phase III | rekrutiert |
| A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial f | Phase I / Phase II | rekrutiert |
| A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world Sett | — | rekrutiert |
| A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies | Phase I / Phase II | rekrutiert |
| A Global Prospective Observational Registry of Patients With Pompe Disease | — | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Long-term Extension Study of PCI-32765 (Ibrutinib) | Phase III | rekrutiert |
| A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace) | — | rekrutiert |
| A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's | Phase II | rekrutiert |
| A Master Protocol (OLMP): A Study of LY4256984 in Participants With Amyotrophic Lateral Sclerosi | Phase I | rekrutiert |
| A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesit | Phase III | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma | Phase II | rekrutiert |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With | Phase III | rekrutiert |
| A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treat | Phase III | rekrutiert |
| A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Sa | Phase III | rekrutiert |
| A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan | Phase III | rekrutiert |
| A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoc | Phase III | rekrutiert |
| A Prospective Observational Trial to Assess Treatment Sequences and Factors That Impact Overall | — | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to | Phase III | rekrutiert |
| A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination Wit | Phase III | rekrutiert |
| A Study Evaluating Mibavademab Treatment of Obesity Due to Leptin (LEP) Gene Mutations in Childr | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs | Phase III | rekrutiert |
| A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients W | Phase I | rekrutiert |
| A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Re | Phase I | rekrutiert |
| A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Ce | Phase III | rekrutiert |
| A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Her | — | rekrutiert |
| A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Ch | Phase III | rekrutiert |
| A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First | Phase III | rekrutiert |
| A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in P | Phase III | rekrutiert |
| A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian C | Phase III | rekrutiert |
| A Study of BGB-11417 in Participants With Myeloid Malignancies | Phase I / Phase II | rekrutiert |
| A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced So | Phase I / Phase II | rekrutiert |
| A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly D | Phase III | rekrutiert |
| A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin | — | rekrutiert |
| A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adju | Phase III | rekrutiert |
| A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Canc | — | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulce | Phase II | rekrutiert |
| A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Phase II / Phase III | rekrutiert |
| A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapse | Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated | Phase II / Phase III | rekrutiert |
| A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis | Phase I | rekrutiert |
| A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adult | Phase II | rekrutiert |
| A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Co | Phase II | rekrutiert |
| A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men | Phase III | rekrutiert |
| A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acal | Phase III | rekrutiert |
| A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis | Phase III | rekrutiert |
| A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Le | Phase III | rekrutiert |
| A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovaria | Phase II / Phase III | rekrutiert |
| A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or L | Phase II | rekrutiert |
| A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NP | Phase I / Phase II | rekrutiert |
| A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tra | Phase III | rekrutiert |
| A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-AD | Phase III | rekrutiert |
| A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-li | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRI | Phase II | rekrutiert |
| A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy | Phase II | rekrutiert |
| A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Particip | Phase II | rekrutiert |
| A Study to Assess Safety, Cellular Kinetics and Exploratory Efficacy of Rapcabtagene Autoleucel | Phase I / Phase II | rekrutiert |
| A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart ( | Phase III | rekrutiert |
| A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradi | Phase III | rekrutiert |
| A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemothe | Phase II / Phase III | rekrutiert |
| A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + | Phase III | rekrutiert |
| A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab P | Phase III | rekrutiert |
| A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease | Phase I | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-M | Phase III | rekrutiert |
| A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD | Phase III | rekrutiert |
| A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migrai | Phase II | rekrutiert |
| A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting | Phase I / Phase II | rekrutiert |
| A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Plac | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzhe | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sc | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moder | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults Wit | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis | Phase II | rekrutiert |
| A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease | Phase II | rekrutiert |
| A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 | Phase III | rekrutiert |
| A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies | Phase IV | rekrutiert |
| A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotocl | Phase III | rekrutiert |
| A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in | Phase I / Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerativ | Phase II | rekrutiert |
| A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis i | Phase II | rekrutiert |
| A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and S | Phase I | rekrutiert |
| A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomi | Phase III | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in | Phase III | rekrutiert |
| A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 | Phase II | rekrutiert |
| A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathi | Phase III | rekrutiert |
| A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis | Phase I | rekrutiert |
| A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part | Phase III | rekrutiert |
| A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Str | Phase II | rekrutiert |
| A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System Atr | Phase II | rekrutiert |
| ATLAS (AltaValve) Pivotal Trial | ohne Phasenangabe | rekrutiert |
| AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platin | Phase III | rekrutiert |
| Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell | Phase III | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA | Phase II / Phase III | rekrutiert |
| An Extension Study to Assess Impact of Multiple Sclerosis (MS) on Physical Function and Provide | Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Mode | Phase III | rekrutiert |
| An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-ter | Phase III | rekrutiert |
| An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing | Phase I / Phase II | rekrutiert |
| An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipopr | Phase III | rekrutiert |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIA | — | rekrutiert |
| BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours | Phase I / Phase II | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination Wit | Phase I / Phase II | rekrutiert |
| Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintena | Phase III | rekrutiert |
| Burden, Mortality and Supply Costs in Intensive Care Unit Patients | — | rekrutiert |
| CAR-T Long Term Follow Up (LTFU) Study | Phase III | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry | — | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Cardiac Biomarkers for the Quantification of Myocardial Damage After Cardiac Surgery | — | rekrutiert |
| Cerebral Small Vessel Disease Progression Dependent on Stroke Type | — | rekrutiert |
| Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Ad | Phase III | rekrutiert |
| Clinical Performance of the New Plasma Filter PX2 in TPE Treatments | ohne Phasenangabe | rekrutiert |
| Clinical Value and Cost-effectiveness of a Personalized Prevention Program (PPP) in Patients Wit | ohne Phasenangabe | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refrac | Phase I / Phase II | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparative Study of Navigation-assisted OrthoPilot® Elite and Robotic-assisted MAKO® Total Knee | — | rekrutiert |
| Comparison of Therapies Before Stem Cell Transplantation in Patients With Higher Risk MDS and Ol | Phase II | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| Cyclosporine In Takotsubo Syndrome | Phase II | rekrutiert |
| DEfeating PEnile CAncer-2 | ohne Phasenangabe | rekrutiert |
| Dazucorilant in Patients With Amyotrophic Lateral Sclerosis | Phase II | rekrutiert |
| Development of the PTSD-iMPACT to Measure PTSD-Related Functional Impairment in Children and Ado | — | rekrutiert |
| Disentangling the Effect of Brain Insulin Resistance on Brain Health | — | rekrutiert |
| Early Catheter-directed Treatment of High Risk Pulmonary Embolism | ohne Phasenangabe | rekrutiert |
| Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody | Phase III | rekrutiert |
| Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients | Phase III | rekrutiert |
| Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK | Phase II | rekrutiert |
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease | Phase II | rekrutiert |
| Efficacy and Safety of Oral Controlled-Ileocolonic-Release Nicotinamide (CICR-NAM) in Patients W | Phase II / Phase III | rekrutiert |
| Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With | Phase III | rekrutiert |
| Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for | Phase II | rekrutiert |
| Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participant | Phase III | rekrutiert |
| Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monog | — | rekrutiert |
| Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia | Phase II | rekrutiert |
| Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) | Phase III | rekrutiert |
| Endometrial Cancer Lymphadenectomy Trial | ohne Phasenangabe | rekrutiert |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | — | rekrutiert |
| European Disease Registry on Retinopathy of Prematurity (ROP) | — | rekrutiert |
| European Larynx Organ Preservation Study (ELOS) [MK-3475-C44] | Phase II | rekrutiert |
| Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides | ohne Phasenangabe | rekrutiert |
| Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Mo | ohne Phasenangabe | rekrutiert |
| Extension Study for the Port Delivery System With Ranibizumab (Portal) | Phase III | rekrutiert |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab i | Phase II / Phase III | rekrutiert |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FL | Phase II | rekrutiert |
| Fertility Protection for Children, Adolescents and Young Adults | — | rekrutiert |
| First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis A | Phase I / Phase II | rekrutiert |
| Fracture Monitor - Femur | ohne Phasenangabe | rekrutiert |
| French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Later | ohne Phasenangabe | rekrutiert |
| Functional Impact of Acute Respiratory Viral Infections in Older Adults | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITIO | Phase II | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| German MPN-Registry for BCR-ABL 1-Negative Myeloid Neoplasms (Study Group Ulm) | — | rekrutiert |
| German Registry of Alzheimer's Disease Treated With Transcranial Pulse Stimulation | — | rekrutiert |
| Glucose-Level During Endurance Exercise | — | rekrutiert |
| HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Deve | — | rekrutiert |
| Hemophagocytosis in Critically Ill Adult Patients | — | rekrutiert |
| HighFLO Study - HighLife Trans-septal Mitral Valve Replacement (TSMVR) Feasibility Study of the | ohne Phasenangabe | rekrutiert |
| Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy | ohne Phasenangabe | rekrutiert |
| Hypercaloric PEG Nutrition in ALS to Sustain Energy Homeostasis | ohne Phasenangabe | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multi | Phase III | rekrutiert |
| Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | Phase II | rekrutiert |
| Immune Modulation by Exosomes in COVID-19 | — | rekrutiert |
| Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Poly | Phase II | rekrutiert |
| Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS) | — | rekrutiert |
| Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | — | rekrutiert |
| Impact of Thyroid Hormones on Human Glucose and Energy Metabolism | ohne Phasenangabe | rekrutiert |
| Imprinting in Metabolic Diseases - Identifying Epigenetic Mechanisms in Human Gestational Diabet | — | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Improved Muscle Metabolism by Combination of Muscle Activation and Protein Substitution ( IMEMPR | ohne Phasenangabe | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International Genetic Obesity Registry | — | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intracoronary Stenting and Additional Results Achieved by ShockWAVE Coronary Lithotripsy | ohne Phasenangabe | rekrutiert |
| Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease ( | Phase I | rekrutiert |
| Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With | Phase I / Phase II | rekrutiert |
| Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH | Phase III | rekrutiert |
| Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untre | Phase III | rekrutiert |
| KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors | Phase I | rekrutiert |
| LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Acti | Phase II | rekrutiert |
| Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells | Phase II / Phase III | rekrutiert |
| Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL Sy | — | rekrutiert |
| Long-term Follow-up of Children Born in the PETN Studies | — | rekrutiert |
| MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) | Phase III | rekrutiert |
| MEASuRE: Metreleptin Effectiveness And Safety Registry | — | rekrutiert |
| Magnetic Resonance Imaging in Metabolic Diseases | — | rekrutiert |
| MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multi | Phase III | rekrutiert |
| Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and | Phase III | rekrutiert |
| Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personalit | ohne Phasenangabe | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) | ohne Phasenangabe | rekrutiert |
| Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis | — | rekrutiert |
| Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory M | Phase III | rekrutiert |
| Multidimensional Assessment of Infant, Parent and Staff Outcomes During a Family Centered Care E | — | rekrutiert |
| NIS to Examine the Effectiveness of TDC in Patients With Metastatic Non-squamous NSCLC and High- | — | rekrutiert |
| NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-ne | Phase III | rekrutiert |
| NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HE | Phase II | rekrutiert |
| Neoadjuvant Darovasertib in Primary Uveal Melanoma | Phase III | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Neuroimmunology Registry and Biobank | — | rekrutiert |
| Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in A | Phase III | rekrutiert |
| Non Interventional German Leptomeningeal Disease Register | — | rekrutiert |
| Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy | Phase IV | rekrutiert |
| Open-label, Multi-center, Phase I/II Study to Assess Safety, Disease Progression and Cellular Ki | Phase I / Phase II | rekrutiert |
| Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Compl | Phase II | rekrutiert |
| PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma | — | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and | — | rekrutiert |
| Pathogen-Reduced Platelet Concentrates: Experience in Routine Practice in Germany | — | rekrutiert |
| Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Mali | Phase I | rekrutiert |
| Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic | Phase II | rekrutiert |
| Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial | Phase II / Phase III | rekrutiert |
| Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothel | Phase II / Phase III | rekrutiert |
| Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Ca | Phase III | rekrutiert |
| Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in | Phase III | rekrutiert |
| Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With New | Phase III | rekrutiert |
| Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as | Phase III | rekrutiert |
| Phase III Study to Evaluate the Safety, Efficacy, and Impact on Quality of Life of Capivasertib | Phase III | rekrutiert |
| Post-Market Clinical Follow Up Study With Navitor Valve | — | rekrutiert |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - POR | Phase III | rekrutiert |